Exclusive | Biocon, Mylan Biosimilar Deal in Last Leg; Serum Institute to Buy Additional Stake of $500 Million in Biocon Biologics: Sources

Adar Poonawalla’s Serum Institute is likely to buy additional stake in Biocon Biologics worth $500 million which will provide the much needed cash to Biocon to pay Mylan in a part equity, part cash deal for biosimilar business.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.